Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this phase II trial is to determine the feasibility and efficacy of
nimotuzumab combined with concurrent chemoradiotherapy for initially inoperable locally
advanced cervical squamous cell carcinoma.